No abstract available
Publication types
-
Clinical Trial
-
Clinical Trial, Phase II
-
News
MeSH terms
-
AIDS Vaccines / toxicity*
-
Acquired Immunodeficiency Syndrome / epidemiology
-
Acquired Immunodeficiency Syndrome / prevention & control*
-
Federal Government
-
HIV Envelope Protein gp120 / immunology
-
HIV Seropositivity
-
Humans
-
Minority Groups
-
National Institutes of Health (U.S.)
-
Recombinant Proteins / immunology
-
Risk Factors
-
Sexually Transmitted Diseases / complications
-
Substance-Related Disorders
-
United States
Substances
-
AIDS Vaccines
-
HIV Envelope Protein gp120
-
Recombinant Proteins